Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial. [electronic resource]
Producer: 20000921Description: 341-4 p. digitalISSN:- 0277-3732
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Chemotherapy, Adjuvant
- Confidence Intervals
- Disease Progression
- Docetaxel
- Female
- Fever -- chemically induced
- Follow-Up Studies
- Gastrectomy
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Neutropenia -- chemically induced
- Paclitaxel -- administration & dosage
- Remission Induction
- Stomach Neoplasms -- drug therapy
- Survival Rate
- Taxoids
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.